Similar articles

• Effect of electroconvulsive therapy on serum myelin basic protein immunoreactivity.

  Hoyle NR, Pratt RT, Thomas DG. Hoyle NR, et al. Br Med J (Clin Res Ed). 1984 Apr 14;288(6424):1110-1. doi: 10.1136/bmj.288.6424.1110. Br Med J (Clin Res Ed). 1984. PMID: 6201225 Free PMC article.
• Myelin basic protein immunoreactivity in serum of neurosurgical patients.

  Thomas DG, Hoyle NR, Seeldrayers P. Thomas DG, et al. J Neurol Neurosurg Psychiatry. 1984 Feb;47(2):173-5. doi: 10.1136/jnnp.47.2.173. J Neurol Neurosurg Psychiatry. 1984. PMID: 6200573 Free PMC article.
• Radioimmunoassay of serum myelin basic protein and its application to patients with cerebrovascular accident.

  Palfreyman JW, Johnston RV, Ratcliffe JG, Thomas DG, Forbes CD. Palfreyman JW, et al. Clin Chim Acta. 1979 Mar 15;92(3):403-9. doi: 10.1016/0009-8981(79)90220-1. Clin Chim Acta. 1979. PMID: 86395
• Electroconvulsive therapy, hypertensive surge, blood-brain barrier breach, and amnesia: exploring the evidence for a connection.

  Andrade C, Bolwig TG. Andrade C, et al. J ECT. 2014 Jun;30(2):160-4. doi: 10.1097/YCT.0000000000000133. J ECT. 2014. PMID: 24800688 Review.
• Serum biomarkers for traumatic brain injury.

  Neher MD, Keene CN, Rich MC, Moore HB, Stahel PF. Neher MD, et al. South Med J. 2014 Apr;107(4):248-55. doi: 10.1097/SMJ.0000000000000086. South Med J. 2014. PMID: 24937520 Review.